Literature DB >> 10508267

Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice.

P J Mee1, M Turner, M A Basson, P S Costello, R Zamoyska, V L Tybulewicz.   

Abstract

The T cell repertoire is shaped by positive and negative selection of thymocytes. TCR-mediated signals that determine these selection processes are only partly understood. The CD45 tyrosine phosphatase has been shown to be important for signal transduction through the TCR, but there has been disagreement about whether CD45 is a positive or negative regulator of TCR signaling. Using CD45-deficient mice expressing transgenic TCR, we show that in the absence of CD45 there is a large increase in the thresholds of TCR stimulation required for both positive and negative selection. Our results conclusively demonstrate that in double-positive thymocytes CD45 is a positive regulator of the TCR signals that drive thymic selection events.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508267     DOI: 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

1.  Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice.

Authors:  M Baker; J Gamble; R Tooze; D Higgins; F T Yang; P C O'Brien; N Coleman; S Pingel; M Turner; D R Alexander
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

2.  Impaired Glycoprotein VI-Mediated Signaling and Platelet Functional Responses in CD45 Knockout Mice.

Authors:  Vaishali V Inamdar; John C Kostyak; Rachit Badolia; Carol A Dangelmaier; Bhanu Kanth Manne; Akruti Patel; Soochong Kim; Satya P Kunapuli
Journal:  Thromb Haemost       Date:  2019-06-21       Impact factor: 5.249

3.  Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival.

Authors:  Julie Zikherman; Kristin Doan; Ramya Parameswaran; William Raschke; Arthur Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-30       Impact factor: 11.205

4.  PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background.

Authors:  Julie Zikherman; Michelle Hermiston; David Steiner; Kiminori Hasegawa; Andrew Chan; Arthur Weiss
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 5.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

6.  Monovalent and multivalent ligation of the B cell receptor exhibit differential dependence upon Syk and Src family kinases.

Authors:  Sayak Mukherjee; Jing Zhu; Julie Zikherman; Ramya Parameswaran; Theresa A Kadlecek; Qi Wang; Byron Au-Yeung; Hidde Ploegh; John Kuriyan; Jayajit Das; Arthur Weiss
Journal:  Sci Signal       Date:  2013-01-01       Impact factor: 8.192

7.  Novel tools to dissect the dynamic regulation of TCR signaling by the kinase Csk and the phosphatase CD45.

Authors:  Ying Xim Tan; Julie Zikherman; Arthur Weiss
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2013-10-07

8.  The structural wedge domain of the receptor-like tyrosine phosphatase CD45 enforces B cell tolerance by regulating substrate specificity.

Authors:  Julie Zikherman; Ramya Parameswaran; Michelle Hermiston; Arthur Weiss
Journal:  J Immunol       Date:  2013-02-08       Impact factor: 5.422

9.  Selective regulation of TCR signaling pathways by the CD45 protein tyrosine phosphatase during thymocyte development.

Authors:  Rustom Falahati; David Leitenberg
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 10.  Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity.

Authors:  Stephanie M Stanford; Novella Rapini; Nunzio Bottini
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.